For people with allergies, ongoing exposure to triggers may create a cycle of inflammation that contributes to polyp ...

Nasal polyps are small noncancerous growths in the nose or sinuses. They may cause pain or pressure in the face, runny or stuffy nose, and other symptoms or complications that may negatively ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...

Researchers recently identified five extrapulmonary treatable traits in asthma that are clinically relevant and have a clear diagnostic process.

IL-5 is present at high levels in nasal polyp tissue. IL-5 inhibitors play ... 2 — which evaluated depemokimab for treating severe asthma characterized by type II inflammation met their primary ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...

The co-primary endpoints were change from baseline in total nasal polyp size (measured by endoscopic total Nasal ... name Tezspire ® for the add-on maintenance treatment of severe asthma in adult and ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...